Using immunohistochemistry, we observed that after the injection of Livin ASODN, the expression of Caspase 3 in tumor tissues increased, which was probably because Livin ASODN inhibited the expression of Livin and then removed the binding inhibition to Caspase 3. Here, CASP3 is linked to neoplasm.